Glenn D. Steele Jr, MD

Articles by Glenn D. Steele Jr, MD

Primary Care Diabetes Bundle Management: 3-Year Outcomes for Microvascular and Macrovascular Events

ByFrederick J. Bloom Jr, MD,Xiaowei Yan, PhD,Walter F. Stewart, PhD,Thomas R. Graf, MD,Tammy Anderer, PhD,Duane E. Davis, MD,Steven B. Pierdon, MD,James Pitcavage, MS,Glenn D. Steele Jr, MD

June 26th 2014

Using a system for primary care management of patients with diabetes may reduce the risk of myocardial infarction, stroke, and retinopathy over a 3-year period.

Latest Updated Articles

Primary Care Diabetes Bundle Management: 3-Year Outcomes for Microvascular and Macrovascular Events
Published: June 26th 2014 | Updated:

Glenn D. Steele Jr, MD

Articles by Glenn D. Steele Jr, MD

Primary Care Diabetes Bundle Management: 3-Year Outcomes for Microvascular and Macrovascular Events

Latest Updated Articles

Trending on AJMC

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

Guidelines for Bronchiectasis Highlight Multiple Treatment Methods

Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD

Radiotherapy Plus Chemo Benefits Certain Patients With DLBCL